Studies have elicited that FAP-expressing CAFs can demonstrate tumor-forming functions in some cancers such as gastric cancer, but also asporin-expressing CAFs were found to inhibit cancer development in breast cancer, offering two different opportunities for therapeutic intervention [86]. The gene discussed is FAP; the disease is breast carcinoma.